Breaking News Instant updates and real-time market news.

CNAT

Conatus

$1.96

-0.04 (-2.00%)

16:15
10/03/16
10/03
16:15
10/03/16
16:15

Conatus announces acceptance of Emricasan abstracts for AASLD annual meeting

Conatus Pharmaceuticals announced that abstracts for four posters - two addressing clinical results and two addressing preclinical results with the company's pan-caspase inhibitor, emricasan - have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, AASLD, in Boston November 11-15.

CNAT Conatus
$1.96

-0.04 (-2.00%)

05/09/16
BMUR
05/09/16
NO CHANGE
Target $7
BMUR
Buy
Conatus price target lowered to $7 from $13 at Brean Capital
Brean Capital lowered its price target on Conatus to $7 from $13 as the firm believes data from its Phase ll liver cirrhosis study has yielded inconclusive results. Brean Capital lowered its price target based on cutting the probability of success for emricasan in liver cirrhosis to 20% from 30%. Brean Capital maintained its Buy rating on Conatus shares, as they believe the company remains on the forefront of developing liver disease treatments.
07/01/16
ROTH
07/01/16
INITIATION
Target $4
ROTH
Buy
Conatus coverage resumed with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv resumed coverage of Conatus with a Buy rating and $4 price target.
08/29/16
HCWC
08/29/16
NO CHANGE
Target $15
HCWC
Buy
Conatus drug further validated by collaboration, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce keeps a Buy rating on Conatus Pharmaceuticals following the company's collaboration agreement with Exalenz Biosciences. The analyst remains positive on Conatus's prospects in non-alcoholic steatohepatitis cirrhosis. The collaboration brings the use of Exalenz's BreathID Methacetin Breath Test to monitor patients in the upcoming Phase 2b trial evaluating the safety and efficacy of emricasan in 160 patients with liver cirrhosis associated with NASH and severe portal hypertension, Arce tells investors in a research note. Using a "simple and non-invasive test provides not only further scientific validation of emricasan for the treatment of NASH cirrhosis, but it also serves as the first non-invasive test that can assist clinicians to conveniently and cost-effectively monitor the effect of the drug at the point of care," the analyst writes. He has a Buy rating on Conatus with a $15 price target.
09/20/16
STFL
09/20/16
NO CHANGE
Target $6
STFL
Buy
Stifel says Conatus emricasan an interesting asset amid increased focus on NASH
Following Allergan's (AGN) acquisition of small-cap NASH play Tobira (TBRA), Stifel analyst Stephen Willey notes there are some "interesting" similarities between Conatus (CNAT) and the latter. However, the analyst points out that the clearest distinctions between the two are Conatus' emphasis on some of the downstream consequences of NASH fibrosis and the amount of meaningful clinical data generated to date. Willey still thinks Conatus' emricasan is an interesting asset, but urges investors seeking Tobira-like premiums to exercise a level of caution. He reiterates a Buy rating and $6 price target on Conatus' shares. In afternoon trading, shares of Conatus have gained about 20% to $2.10.

TODAY'S FREE FLY STORIES

P

Pandora

$13.22

-0.36 (-2.65%)

11:51
02/21/17
02/21
11:51
02/21/17
11:51
Periodicals
Pandora looks to country music to boost subscription aspirations, WSJ says »

Internet radio giant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 28

    Feb

  • 19

    Mar

GPC

Genuine Parts

$98.26

-2.41 (-2.39%)

11:49
02/21/17
02/21
11:49
02/21/17
11:49
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TRVN

Trevena

$7.13

0.1 (1.42%)

11:47
02/21/17
02/21
11:47
02/21/17
11:47
Recommendations
Trevena analyst commentary  »

Jefferies sees hospital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 21

    Mar

PRGO

Perrigo

$84.36

-0.11 (-0.13%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Hot Stocks
Perrigo raises dividend to 16c from 14.5c per share »

Perrigo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 21

    Mar

GPC

Genuine Parts

$98.41

-2.26 (-2.25%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AMAT

Applied Materials

$35.67

0.49 (1.39%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Options
Applied Materials call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

DISCA

Discovery

$28.68

0.11 (0.39%)

11:45
02/21/17
02/21
11:45
02/21/17
11:45
Conference/Events
Discovery management to meet with Jefferies »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

11:45
02/21/17
02/21
11:45
02/21/17
11:45
General news
Breaking General news story  »

Philadelphia Federal…

EFX

Equifax

$129.38

-0.76 (-0.58%)

11:42
02/21/17
02/21
11:42
02/21/17
11:42
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.46

-2.2124 (-2.20%)

11:41
02/21/17
02/21
11:41
02/21/17
11:41
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

, KHC

Kraft Heinz

$96.65

9.37 (10.74%)

11:38
02/21/17
02/21
11:38
02/21/17
11:38
Hot Stocks
Mondelez takeover speculation lifts shares as Kraft walks from Unilever »

Shares of Mondelez (MDLZ)…

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

UL

Unilever; also tag UN

$44.54

-3.99 (-8.22%)

UN

Unilever; also tag UL

$44.77

-4.025 (-8.25%)

BRK.A

Berkshire Hathaway

$254,021.52

1183.52 (0.47%)

BRK.B

Berkshire Hathaway

$169.35

0.78 (0.46%)

GIS

General Mills

$60.68

1.45 (2.45%)

K

Kellogg

$74.17

1.27 (1.74%)

CPB

Campbell Soup

$58.60

0.12 (0.21%)

CL

Colgate-Palmolive

$73.15

1.17 (1.63%)

KMB

Kimberly-Clark

$133.18

1.25 (0.95%)

CLX

Clorox

$134.98

1.27 (0.95%)

HSY

Hershey

$108.33

1.08 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

  • 19

    Mar

11:38
02/21/17
02/21
11:38
02/21/17
11:38
General news
6-Month Bill Auction Bid/Cover data reported »

6-Month Bill Auction…

11:38
02/21/17
02/21
11:38
02/21/17
11:38
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:37
02/21/17
02/21
11:37
02/21/17
11:37
General news
3-Month Bill Auction Bid/Cover data reported »

3-Month Bill Auction…

11:37
02/21/17
02/21
11:37
02/21/17
11:37
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

, QSR

Restaurant Brands

$57.55

3.65 (6.77%)

11:36
02/21/17
02/21
11:36
02/21/17
11:36
Downgrade
Popeyes, Restaurant Brands rating change  »

Popeyes downgraded to…

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

QSR

Restaurant Brands

$57.55

3.65 (6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 23

    Mar

HLF

Herbalife

$61.22

-0.01 (-0.02%)

11:36
02/21/17
02/21
11:36
02/21/17
11:36
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.10

-1.57 (-1.56%)

11:32
02/21/17
02/21
11:32
02/21/17
11:32
Hot Stocks
Genuine Parts sees FY17 automotive, industrial sales up 3%-4% »

Says U.S. sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

11:30
02/21/17
02/21
11:30
02/21/17
11:30
General news
The Bund/T-note spread continued to widen to -212 bp »

The Bund/T-note spread…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:27
02/21/17
02/21
11:27
02/21/17
11:27
Hot Stocks
Breaking Hot Stocks news story on Felcor Lodging, Ashford Hospitality »

Felcor: Company, Ashford…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:26
02/21/17
02/21
11:26
02/21/17
11:26
Hot Stocks
Breaking Hot Stocks news story on Felcor Lodging, Ashford Hospitality »

Felcor Lodging says has…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

COP

ConocoPhillips

$48.37

0.86 (1.81%)

11:26
02/21/17
02/21
11:26
02/21/17
11:26
Options
ConocoPhillips call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

FCH

Felcor Lodging

$7.87

0.64 (8.85%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Hot Stocks
Felcor Lodging confirms unsolicited offer from Ashford Hospitality »

FelCor Lodging Trust…

FCH

Felcor Lodging

$7.87

0.64 (8.85%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Conference/Events
CFA Society of Philadelphia to hold a luncheon meeting »

Luncheon Meeting where…

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Conference/Events
Federal Reserve Bank of Philadelphia President speaks on economic outlook »

Philadelphia Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.